BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1576731)

  • 1. Effect of cyclooxygenase blockade on blood flow through well-developed coronary collateral vessels.
    Altman J; Dulas D; Bache RJ
    Circ Res; 1992 Jun; 70(6):1091-8. PubMed ID: 1576731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin on coronary collateral blood flow.
    Altman JD; Dulas D; Pavek T; Bache RJ
    Circulation; 1993 Feb; 87(2):583-9. PubMed ID: 8425302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial function in well-developed canine coronary collateral vessels.
    Altman J; Dulas D; Pavek T; Laxson DD; Homans DC; Bache RJ
    Am J Physiol; 1993 Feb; 264(2 Pt 2):H567-72. PubMed ID: 8447468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of canine coronary collateral vessels to ergonovine and alpha-adrenergic stimulation.
    Bache RJ; Foreman B; Hautamaa PV
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1019-25. PubMed ID: 1681740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of coronary collateral vasoconstriction in response to cyclooxygenase blockade.
    Altman JD; Bache RJ
    Circ Res; 1994 Feb; 74(2):310-7. PubMed ID: 8293570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atrial natriuretic peptide on coronary collateral blood flow.
    Foreman B; Dai XZ; Homans DC; Laxson DD; Bache RJ
    Circ Res; 1989 Dec; 65(6):1671-8. PubMed ID: 2531047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels.
    Wright L; Homans DC; Laxson DD; Dai XZ; Bache RJ
    J Am Coll Cardiol; 1992 Mar; 19(3):687-93. PubMed ID: 1538028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase blockade limits blood flow to collateral-dependent myocardium during exercise.
    Altman JD; Klassen CL; Bache RJ
    Cardiovasc Res; 1995 Nov; 30(5):697-704. PubMed ID: 8595615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasomotor responses of newly developed coronary collateral vessels.
    Kinn JW; Altman JD; Chang MW; Bache RJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):H490-7. PubMed ID: 8770088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.
    Traverse JH; Judd D; Bache RJ
    Circulation; 1996 Feb; 93(3):558-66. PubMed ID: 8565176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature.
    Quebbeman BB; Dulas D; Altman J; Homans DC; Bache RJ
    J Cardiovasc Pharmacol; 1993 May; 21(5):774-80. PubMed ID: 7685448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in coronary vasodilator reserve following coronary occlusion and reperfusion in anesthetized dog: role of endothelium-derived relaxing factor, myocardial neutrophil infiltration and prostaglandins.
    Nichols WW; Mehta JL; Donnelly WH; Lawson D; Thompson L; ter Riet M
    J Mol Cell Cardiol; 1988 Oct; 20(10):943-54. PubMed ID: 2851052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs.
    Lamping KA; Gross GJ
    J Cardiovasc Pharmacol; 1984; 6(4):601-8. PubMed ID: 6206313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region.
    Traverse JH; Kinn JW; Klassen C; Duncker DJ; Bache RJ
    J Am Coll Cardiol; 1998 Jan; 31(1):67-74. PubMed ID: 9426020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise.
    Traverse JH; Altman JD; Kinn J; Duncker DJ; Bache RJ
    Circulation; 1995 Mar; 91(5):1560-7. PubMed ID: 7867199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production.
    Klassen CL; Traverse JH; Bache RJ
    Am J Physiol; 1999 Sep; 277(3):H918-23. PubMed ID: 10484411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes in collateral blood flow to ischemic myocardium and their influence on bimodal vulnerability during the first 30 min of acute coronary artery occlusion in dogs.
    von Mutius S; Neumann M; Meesmann W
    Basic Res Cardiol; 1988; 83(1):94-106. PubMed ID: 3377745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in collateral blood flow produced by isoflurane in a chronically instrumented canine model of multivessel coronary artery disease.
    Hartman JC; Kampine JP; Schmeling WT; Warltier DC
    Anesthesiology; 1991 Jan; 74(1):120-33. PubMed ID: 1986637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise.
    Foreman BW; Dai XZ; Bache RJ
    Circ Res; 1991 Sep; 69(3):657-64. PubMed ID: 1873862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.